Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: Nat Genet. 2008 Feb 10;40(3):281–283. doi: 10.1038/ng.89

Table 1.

Association results for rs5945572 on Xp11.22 and prostate cancer in Iceland, The Netherlands, Spain, Sweden and the United States

Study population
(cases/controls)
Frequency

Variant (allele) Cases Controls OR (95% c.i.) P value
Iceland (1,833/21,372)a
rs5945572 (A) 0.414 0.368 1.21 (1.09 – 1.34) 3.36 × 10−4
Holland (991/2,021)
rs5945572 (A) 0.390 0.347 1.20 (1.04 – 1.39) 0.015
Spain (539/1,594)
rs5945572 (A) 0.432 0.364 1.33 (1.10 – 1.61) 3.20 × 10−3
Sweden (2,865/1,722)
rs5945572 (A) 0.421 0.379 1.19 (1.05 – 1.34) 4.84 × 10−3
Baltimore, Maryland (1,516/554)
rs5945572 (A) 0.397 0.334 1.31 (1.07 – 1.60) 8.39 × 10−3
Chicago, Illinois (656/503)
rs5945572 (A) 0.402 0.354 1.23 (0.98 – 1.54) 0.072
Nashville, Tennessee (526/612)
rs5945572 (A) 0.392 0.353 1.18 (0.93 – 1.50) 0.18
Rochester, Minnesota (1,128/500)b
rs5945572 (A) 0.381 0.306 1.40 (1.11 – 1.76) 4.39 ×10−3
All excluding Iceland (8,221/7,506)c
rs5945572 (A) 0.348 1.24 (1.16 – 1.33) 2.57 × 10−10
All combined (10,054/28,879)c
rs5945572 (A) 0.351 1.23 (1.16 – 1.30) 3.95 × 10−13

All P values shown are two-sided. Shown are the corresponding numbers of cases and controls (n), allelic frequencies of variants in affected and control individuals, the allelic odds ratio (OR) with 95% confidence interval (95% c.i.) and P values. For additional information on assays and frequencies, see Supplementary Tables 4 and 5 online.

a

Results presented for Iceland were adjusted for relatedness using a method of genomic control (see Supplementary Methods).

b

Results presented for the Rochester study group were adjusted for relatedness by applying a pedigree correction factor (see Supplementary Methods).

c

For the combined study populations, the reported control frequency was the average, unweighted control frequency of the individual populations, whereas the OR and the P value were estimated using the Mantel-Haenszel model.